IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 303 participants.

Also called NCT01226563

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 303 participants (enrolled count) (from the registry)
Sponsor
Bellerophon BCM LLC (from the registry)
Registry
  • NCT NCT01226563
Other papers using this trial's data
  • Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction Journal of the American College of Cardiology, 2016-08-16 DOI, PubMed 27515331

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Australia, Belgium, Canada, France, Germany, Israel, Poland, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01226563. Randomized; triple masking; primary purpose prevention. Start 2012-04 (registry gives no type); primary completion 2015-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
Acronym
PRESERVATION-1
Condition
Acute Myocardial Infarction
Condition
Congestive Heart Failure
Condition
ST-Elevation Myocardial Infarction
Intervention (Device)
IK-5001
Intervention (Device)
Saline Solution
Lead sponsor
Bellerophon BCM LLC (class: industry)

Record details

Record id
cardio:ct-nct01226563
Content hash
b9670f61ab63461be8fd0c00b8c2e427ee671a78f1a87cbc81293a676c07ea22